ESSA Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-26.58	-35.1	-36.81	-23.45	-12.76	-11.63	-4.5	-13.14	-9.68	-1.82
Depreciation & Amortization	0.12	0.12	0.11	0.11	0	0.03	0.05	0.07	0.04	0.02
Share-Based Compensation	5.01	7.89	9.48	7.52	1.15	1.4	0.76	1.25	1.51	0.49
Other Operating Activities	1.67	-0.91	1.8	-1.17	-0.64	-0.02	-13.66	-3.47	-5.22	-0.77
Operating Cash Flow	-19.78	-28	-25.42	-16.98	-12.25	-10.22	-17.35	-15.3	-13.34	-2.08
Capital Expenditures	0	0	0	0	0	0	0	-0.01	-0.17	0
Change in Investments	-3.53	-53.05	-35.01	-21.74	0.2	-0.2	0	0	0	0
Investing Cash Flow	-3.53	-53.05	-35.01	-21.74	0.2	-0.2	0	-0.01	-0.17	0
Share Issuance / Repurchase	0.07	0.39	151.32	49.07	36	0	0	0.04	13.29	2.18
Debt Issued / Paid	-0.14	-0.13	-0.1	-4.04	-3.21	24.05	8	20	0	0.91
Other Financing Activities	-	-	-9.23	-3.26	17.77	-2.74	4.32	2.71	-0.7	2.56
Financing Cash Flow	-0.07	0.25	141.99	41.78	50.56	21.31	12.33	22.74	12.59	5.66
Exchange Rate Effect	0	0.05	-0.06	-0.06	-0.02	-0.02	0	-0.03	-1.2	-0.1
Net Cash Flow	-23.37	-80.75	81.5	3	38.49	10.87	-5.03	7.41	-2.12	3.47
Free Cash Flow	-19.78	-28	-25.42	-16.98	-12.25	-10.22	-17.35	-15.31	-13.51	-2.08
Free Cash Flow Per Share	-0.45	-0.64	-0.66	-0.76	-1.45	-2.24	-11.93	-11.38	-14.73	-2.65

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).